Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front

Oncogene

Volumn 20, Issue 16, 2001, Pages 1981-1989

  Pjaweletz, Cloud P ^a,b,c   Charboneau, Lu ^b   Bichsel, Verena E ^a,b   Simone, Nicole L ^b   Chen, Tina ^b   Gillespie, John W ^b   Emmert Buck, Michael R ^b   Roth, Mark J ^b   Petricoin III, Emanuel F ^a   Liotta, Lance A ^b  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c GEORGETOWN UNIVERSITY   (United States)

Author keywords

Akt; Apoptosis; Laser capture microdissection; Mitogen activated protein kinase; Protein microarrays; Tumor progression

Indexed keywords

LIPOCORTIN 1; MITOGEN ACTIVATED PROTEIN KINASE;

APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INVASION; CONTROLLED STUDY; DISEASE COURSE; DISEASE MARKER; DNA MICROARRAY; ESOPHAGUS CANCER; HUMAN; HUMAN CELL; INVASIVE CARCINOMA; LABORATORY TEST; MAJOR CLINICAL STUDY; PHOSPHORYLATION; PRIORITY JOURNAL; PROSTATE CANCER; REVERSE PHASE PROTEIN MICROARRAY;

CELL DIVISION; CELL SURVIVAL; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; DISSECTION; EPITHELIAL CELLS; HUMANS; LASERS; MALE; MITOGEN-ACTIVATED PROTEIN KINASES; NEOPLASM PROTEINS; PHOSPHORYLATION; PROSTATE; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION; TUMOR MARKERS, BIOLOGICAL;

EID: 0035848705     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1204265     Document Type: Article

References (39)

1. Arenkov P, Kukhtin A, Gemmell A, Voloshchuk S, Chupeeva V and Mirzabekov A. (2000). Anal. Biochem., 278, 123-131.
2. Bostwick DG. (1995). Cancer, 75, 1823-1836.
3. Buckholtz RG, Simmons CA, Stuart JM and Weiner MP. (1999). J. Mol. Microbiol. Biotechnol., 1, 135-140.
4. Cross DAE, Alessi DR, Cohen P, Adndjelkovich M and Hedmmings BA. (1995). Nature, 378, 785-788.
5. DeRisi J, Penland L, Brown PO, Bittner ML, Meltzer PS, Ray M, Chen Y, Su YA and Trent JM. (1996). Nat. Genet., 4, 457-460.
6. Dimmeler S and Zeiher AM. (2000). Circ. Res., 86, 4-5.
7. Ekins RP and Chu FW. (1991). Clin. Chem., 37, 1955-1967.
8. Emili AQ and Cagney G. (2000). Nat. Biotechnol., 18, 393-397.
9. Emmert-Buck MR, Bonner RF, Smith PD, Chuaqui RF, Zhuang Z, Goldstein S and Liotta LA. (1996). Science, 274, 1481-1483.
10. Emmert-Buck MR, Gillespie JW, Paweletz CP, Ornstein DK, Basrur V, Appella E, Wang QH, Huang J, Hu N, Taylor P and Petricoin III EF. (2000). Mol. Carcinog., 27, 158-165.
11. Englert CR, Baibakov GV and Emmert-Buck MR. (1999). Cancer Res., 60, 1526-1530.
12. Fodor SPA, Read JL, Pirrung MC, Stryer L, Lu AT and Solas D. (1991). Science, 251, 767-773.
13. Franke TF, Kaplan DR and Cantley LC. (1997). Cell, 88, 435-437.
14. Frey RS and Mulder KM. (1997). Cancer Res., 57, 628-633.
15. Ge H. (2000). Nucleic Acid Res., 28, e3.
16. Gioeli D, Mandell JW, Petroni GR, Frierson Jr HF and Weber MJ. (1999). Cancer Res., 59, 279-284.
17. Graff JR, Konicek BW, McNulty AM, Wang ZJ, Houck K, Allen S, Paul JD, Hbaiu A, Goode RG, Sandusky GE, Vessella RL and Neubauer BL. (2000). JBC., 275, 24500-24505.
18. Haab BB, Dunham JM and Brown PO. (2001). Genome Biology, 2, 1-13.
19. Hanahan D and Weinberg RA. (2000). Cell, 100, 57-70.
20. Jones WV, Kenseth JR, Porter MD, Mosher CL and Henderson E. (1998). Anal. Chem., 70, 1233-1241.
21. Koch M, Miguel M, de Hoefler H and Diaz-Cano SJ. (2000). Virchows Arch., 436, 413-420.
22. Kononen J, Bubendorf L, Kallioniemi A, Bärlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G and Kallioniemi OP. (1998). Nat. Med., 4, 844-847.
23. Krajewaska M, Krajewski S, Epstein JI, Shabaik A, Sauvageot J, Song K, Kitada S and Reed JC. (1996). Am. J. Pathol., 1148, 1567-1576.
24. Lipshutz RJ, Fodor SP, Gingeras TR and Lockhart DJ. (1999). Nat. Genet., 1 (suppl), 20-24.
25. Lueking A, Horn M, Eickhoff H, Büssow K, Lehrach H and Walter G. (1999). Anal. Biochem., 270, 103-111.
26. MacBeath G, Koehler AN and Schreiber SL. (1999). JACS, 121, 7966-7968.
27. Marshall CJ. (1995). Cell, 80, 179-185.
28. Ornstein DK, Gillespie JW, Paweletz CP, Duray PH, Herring J, Vocke CD, Topalian SZ, Bostwick DG, Linehan WM, Petricoin III EF and Emmert-Buck MR. (2000). Electrophoresis, 21, 2235-2242.
29. Page MJ, Amess B, Townsend RR, Parekh R, Herath A, Brusten L, Zvelebil MJ, Stein RC, Waterfield MD, Davies SC and O'Hare MJ. (2000). PNAS, 96, 12589-12594.
30. Pap M and Cooper GM. (1998). JBC, 273, 19929-19932.
31. Paweletz CP, Ornstein DK, Roth MJ, Bichsel VE, Gillespie JW, Calvert VS, Vocke CD, Hewitt SM, Duray PH, Herring J, Wang QH, Hu N, Lineham WM, Taylor PR, Liotta LA, Emmert-Buck MR and Petricoin EF. (2000). Cancer Res., 60, 6293-6297.
32. Rowe AC, Tender LM, Feldstein MJ, Golden JP, Scruggs SB, MacCraith BD, Cras JJ and Ligler FS. (1999). Anal. Chem., 71, 3846-3852.
33. Schena M, Shalon D, Davis RW and Brown PO. (1995). Science, 270, 467-470.
34. Williams KL and Hochstrasser DF. (1997). Proteome Research: New Frontiers in Functional Genomics. Wilkins MR, Williams KL, Appel RD and Hochstrasser DF (eds). Springer: Berlin, Germany, 1-11.
35. Xie W, Wong YC and Tsao SW. (2000). Prostate, 44, 31-39.
36. Yao R and Cooper G. (1995). Science, 267, 2003-2006.
37. York RD, Yao H. Dillon T, Ellig CL, Eckert SP, McClesky EW and Stork PJS. (1998). Nature, 392, 622-626.
38. Zheng DQ, Woodward AS, Tallini G and Languino LR. (2000). JBC, 275, 24565-24574.
39. Zimmermann S and Moelling K. (1999). Science, 286, 1741-1744.